U.S. Markets closed

Pacira Pharmaceuticals, Inc. (PCRX)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
47.45-0.40 (-0.84%)
At close: 4:00PM EDT
People also watch
SUPNPTLAIRWDCLVSPTCT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue276,371248,997197,668
Cost of Revenue110,10471,83777,440
Gross Profit166,267177,160120,228
Operating Expenses
Research Development45,67828,66218,731
Selling General and Administrative152,613139,043106,662
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-32,0249,455-5,165
Income from Continuing Operations
Total Other Income/Expenses Net1,241390-100
Earnings Before Interest and Taxes-30,7839,845-5,265
Interest Expense7,0617,7258,278
Income Before Tax-37,8442,120-13,543
Income Tax Expense105264173
Minority Interest---
Net Income From Continuing Ops-37,9491,804-13,716
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-37,9491,856-13,716
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-37,9491,856-13,716